LSE · Healthcare

Creo Medical Group PLC (CREO)

Medical Devices

Creo Medical Group PLC (CREO) is listed on LSE in the Healthcare sector. Industry: Medical Devices. As of 2026-05-19, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for CREO

P/E ratio

18.00

Creo Medical Group PLC (CREO) — FAQ

What is CREO's P/E ratio?

The price-to-earnings (P/E) ratio for Creo Medical Group PLC (CREO) is 18.00 (data as of 2026-05-19).

Does Creo Medical Group PLC pay a dividend?

Dividend yield is not available in the current snapshot for Creo Medical Group PLC (CREO). Check the MyAverix Finance app for the latest dividend data.

What sector is Creo Medical Group PLC in?

Creo Medical Group PLC (CREO) is classified in the Healthcare sector (Medical Devices industry).

What exchange is CREO listed on?

CREO is listed on LSE.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)